This brand name is authorized in Spain, Poland, United Kingdom
The drug ATROLAK contains one active pharmaceutical ingredient (API):
|
1
Quetiapine
UNII 2S3PL1B6UJ - QUETIAPINE FUMARATE
|
|
Quetiapine is an atypical antipsychotic agent. Quetiapine and the active human plasma metabolite, norquetiapine interact with a broad range of neurotransmitter receptors. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ATROLAK Prolonged-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AH04 | Quetiapine | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 74755, 74757, 74758, 77977, 81048 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 278423, 278425, 278427, 278429, 349369 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100261341, 100261358, 100261364, 100303884, 100373301 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
